Skip to main content
NKTR logo

NKTR

Nektar Therapeutics

$30.23

7.10%

Trade Ideas Performance

Latest Closed Trade Idea

$30.23

7.10%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

3

Social

23

About

Events of Nektar Therapeutics (NKTR)

Nektar Therapeutics' stock price experienced significant fluctuations over the past six months, declining by 38.37% from $59.92 on November 3, 2025, to $36.93 on November 2, 2026, and trading between a 52-week high of $109.00 and a low of $33.40. Key events included the Q2 2026 financial results on August 13, 2026, which reported a net loss of $40.6 million and revenues of $10.1 million, causing a 3.8% stock decline despite a strong cash position; the company also announced the initiation of Phase 3 clinical trials for rezpegaldesleukin in atopic dermatitis and plans for a Phase 3 study in alopecia areata. On October 1, 2026, shares plunged 22.39% after new clinical trial data for rezpegaldesleukin in severe alopecia areata showed waning off-treatment durability and a delayed timeline for commercialization, pushing Phase 3 testing to early 2027, leading to an eight-month low for the stock. In October 2026, Leerink Partners initiated coverage with an "Outperform" recommendation, UBS initiated with a "Neutral" rating, Raymond James initiated with a "Market Perform" recommendation, and BTIG reiterated its "Buy" rating. Nektar is scheduled to report its Q3 2026 results on November 12, 2026, with consensus estimates anticipating a net loss of approximately $2.07 per share on revenue of about $10.27 million.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)